Evidence map›Paper›PMID 37003463›Full record

Trial reportJournal of vascular surgery. Venous and lymphatic disorders2023

Ovarian vein surgical ablation versus endovascular technique for treatment of pelvic vein incompetence.

Mohamed Emad El Din, Mosaad Soliman, Yasser El Kiran, Samer Regal, Hamed Youssef, Hossam Elwakeel, Reem Soliman

Open access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of vascular surgery. Venous and lymphatic disorders, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Identification of outcomes in clinical studies for pelvic venous disorders.Journal of vascular surgery. Venous and lymphatic disorders · 2024
    Pooled it
  2. Laparoscopic excision of a coil-loaded ovarian vein for refractory pelvic pain after embolization: A case report.International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics · 2026
    Article
  3. Article
  4. The state of equipoise in chronic venous origin pelvic pain: Behold the beast.Journal of vascular surgery. Venous and lymphatic disorders · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Mohamed Emad El DinVascular Surgery Department, Mansoura Faculty of Medicine, Mansoura, Egypt.
Mosaad SolimanVascular Surgery Department, Mansoura Faculty of Medicine, Mansoura, Egypt. Electronic address: soliman_mosaad@hotmail.com.
Yasser El KiranVascular Surgery Department, Mansoura Faculty of Medicine, Mansoura, Egypt.
Samer RegalVascular Surgery Department, Mansoura Faculty of Medicine, Mansoura, Egypt.
Hamed YoussefObstetrics and Gynecology Department, Mansoura Faculty of Medicine, Mansoura, Egypt.
Hossam ElwakeelVascular Surgery Department, Mansoura Faculty of Medicine, Mansoura, Egypt.
Reem SolimanVascular Surgery Department, Mansoura Faculty of Medicine, Mansoura, Egypt.
Mansoura University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveChronic pelvic pain in women is a disorder brought on by pelvic vein incompetence (PVI). In this prospective, randomized study, the effects of percutaneous coil embolization and surgical ovarian vein ligation and division combined with retrograde sclerotherapy were compared with regard to ovarian vein occlusion, improvement of pelvic congestion symptoms, and their influence on estradiol level after intervention.

methodsA total of 50 patients with PVI were enrolled, with a mean age of 31.9 ± 4.7 years and a pain score of 9 (range, 0-10; from 0 [no pain] to 10 [the highest level of pain]). Both percutaneous coil embolization of ovarian veins (endovascular group) and surgical ovarian vein ablation with retrograde sclerotherapy were offered to the patients at random.

resultsIn the open group, the pain level decreased to 2, whereas in the endovascular group, it decreased to 1 (range, 0-10). Estradiol levels were 224 (range, 9-612) in the open group and 478 (range, 18-613) in the endovascular group before the intervention, with no significant change (P = .1120). After 1 week of intervention, estradiol levels in the open group were 89 (range, 18-243) and 124 (range, 22-298) in the endovascular group, respectively, with statistical insignificance (P = .225). After 1 month of intervention, the endovascular group's estradiol level was 101 (range, 20-196) and the open group's was 89 (range, 15-190) (P = .382). After 3 months of intervention, the open group's estradiol level was 78 (range, 12-132) and the endovascular group's was 65 (range, 18-110) (P = .045).

conclusionsIn addressing PVI, both methods seemed to have promising results. Nevertheless, endovascular management was more effective at decreasing estrogen levels and relieving discomfort. Three months should be the time at which estradiol levels are measured, because this is when they are at their lowest. In both the open and endovascular groups as well as in the pooled data, there was a significant association between estradiol level from before the intervention and improvement in pain scores (P = .005). Because it was linked to a lower pain score, the high preoperative estradiol level can be used to predict postintervention improvement.

Indexed as

Chronic PainEndovascular ProceduresVaricose VeinsAdultEstradiolFemaleHumansPelvic PainPhlebographyTreatment OutcomeEstradiolEndovascularEstradiolPelvic congestion

Identifiers

PMID37003463
PMCPMC12433823
OpenAlexW4361247992

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.